Vascular targeting of solid and ascites tumours with antibodies to vascular endothelial growth factor

European Journal of Cancer Part A

Volumn 32, Issue 14, 1996, Pages 2467-2473

  Ke Lin, ^a   Qu Hong, ^a   Nagy, J A ^a   Eckelhoefer, I A ^a   Masse, E M ^a   Dvorak, A M ^a   Dvorak, H F ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ENDOTHELIAL CELL GROWTH FACTOR;

ANIMAL CELL; ARTICLE; ASCITES TUMOR; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ASCITES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HISTOCYTOCHEMISTRY; LYMPHOKINES; MAMMARY NEOPLASMS, EXPERIMENTAL; MELANOMA, EXPERIMENTAL; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS; OVARIAN NEOPLASMS; RADIOIMMUNOASSAY; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0030484706     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00391-7     Document Type: Article

References (30)

1. 1. Borden EC, Schlom J. Williamsburg Conference on Biological and Immunological Treatments for Cancer, 1992. J Natl Cancer Inst 1993, 85, 1288-1293.
2. 2. Waldmann TA. Monoclonal antibodies in diagnosis and therapy. Science 1991, 252, 1657-1662.
3. 3. Shockley TR, Lin K, Sung C, et al. A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels. Cancer Res 1992, 52, 357-366.
4. 4. Shockley TR, Lin K, Nagy JA, Tompkins RG, Yarmush ML, Dvorak HF. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res 1992, 52, 367-376.
5. 5. Sung C, Shockley TR, Morrison PF, Dvorak HF, Yarmush ML, Dedrick RL. Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors. Cancer Res 1992, 52, 377-384.
6. 6. Dvorak HF, Nagy JA, Dvorak AM. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 1991, 3, 77-85.
7. 7. Jain RK. Haemodynamic and transport barriers to the treatment of solid tumours. Int J Radiat Biol 1991, 60, 85-100.
8. 8. Lin K, Nagy JA, Xu H, Shockley TR, Yarmush ML, Dvorak HF. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts. Cancer Res 1994, 54, 2269-2277.
9. 9. Dvorak HF, Sioussat TM, Brown LF, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991, 174, 1275-1278.
10. 10. Plate KH, Breier G, Welch HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359, 845-848.
11. 11. Senger D, Van De Water L, Brown L, et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 1993, 12, 303-324.
12. 12. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146, 1029-1039.
13. 13. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992, 13, 18-32.
14. 14. Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996, 271, 603-606.
15. 15. Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. J Cell Biochem 1991, 47, 219-223.
16. 16. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255, 989-991.
17. 17. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991, 6, 1677-1683.
18. 18. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993, 53, 4727-4735.
19. 19. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993, 143, 1255-1262.
20. 20. Nagy JA, Masse EM, Herzberg KT, et al. Pathogenesis of ascites tumor growth. Vascular permeability factor, vascular hyperpermeability and ascites fluid accumulation. Cancer Res 1995, 55, 360-368.
21. 21. Qu-Hong, Nagy JA, Senger DR, Dvorak HF, Dvorak AM. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium. J Histochem Cytochem 1995, 43, 381-389.
22. 22. Siouassat TM, Dvorak HF, Brock TA, Senger DR. Inhibition of vascular permeability factor (vascular endothelial growth factor) with anti-peptide antibodies. Arch Biochem Biophys 1993, 301, 15-20.
23. 23. Yeo K-T, Wang HH, Nagy JA, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993, 53, 2912-2918.
24. 24. Nagy J, Morgan E, Herzberg K, Manseau E, Dvorak AM, Dvorak HF. Pathogenesis of ascites tumor growth. Angiogenesis, vascular remodeling and stroma formation in the peritoneal lining. Cancer Res 1995, 55, 376-385.
25. 25. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993, 362, 841-844.
26. 121. Cancer Res 1995, 55, 5296-5301.
27. 27. Dvorak HF, Harvey VS, McDonagh J. Quantitation of fibrinogen influx and fibrin deposition and turnover in line 1 and line 10 guinea pig carcinomas. Cancer Res 1984, 44, 3348-3354.
28. 28. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988, 133, 95-109.
29. 29. Day E, Planisek J, Pressman D. Localization in vivo of radioiodinated anti-rat fibrin antibodies and radioiodinated rat fibrinogen in the Murphy rat lymphosarcoma and in other transplantable rat tumors. J Natl Cancer Inst 1959, 22, 413-426.
30. 30. Fifth Conference on Radioimmunodetection and Radioimmunotherapy of Cancer. In Goldenberg D, ed 55. Princeton, NJ. Cancer Res 1995, (Suppl.), 5704s-5989s.